ActHIB Vaccine Found to Contain Pieces of Glass Between 2013 and 2015
In 2013, pharmaceutical firm Sanofi Pasteur issued no recalls after finding glass shards in vials of ActHIB, its conjugate vaccine containing Haemophilus b and meningococcal protein that is given to infants at two, four, six and between 15 and 18 months of age. The public was not informed until the end of 2016, when…
Australian Biotech Firm Develops New Sugar-Based Adjuvants
Vaxine Pty Ltd., a biotechnology company based in Adelaide, Australia, has developed new adjuvants to be used in vaccines. The firm has received funding from the U.S. National Institutes of Health (NIH) to develop polysaccharide adjuvants—carbohydrates whose molecules consist of sugar molecules bonded together.
Vaccines Against Painkiller Drugs Coming Soon
Highly addictive opioid drugs, including morphine, codeine, oxycodone, and hydrocodone, among others, are not only the most common agents used for pain management throughout the world but also are an increasingly common culprit in today’s addiction epidemic of addiction. It is not only recreational thrill seekers who get into…
Intramuscular Injection May Lead to Nerve Damage
Drug and biological product administration via intramuscular injections using hypodermic needles has been a common medical practice for several centuries and is not going anywhere soon—from vaccines, antibiotics and insulin to an experimental injectable male contraceptive in development. The main issue…
Two Children Die After Polio Vaccination, Four in Critical Condition in Pakistan
Two children in the Tehsil Bara area of the Khyber Agency tribal region in Pakistan reportedly died last week “moments” after receiving the live oral poliovirus vaccine (OPV). Another 11 children, who had been administered the vaccine in Tehsil Bara, fell unconscious and were taken to Hayatabad hospital in the city of Peshawar. Four of the…
Takeda To Build Dengue Vaccine Manufacturing Plant in Germany
Headquartered in Japan, Takeda Pharmaceutical Company Ltd. is the largest pharmaceutical company in Asia and is speeding up development of a vaccine for dengue fever—a mosquito-borne flavivirus disease. The Japanese drugmaker has initiated a 20,000 patient based Phase 3 study in Asia and Latin America to test its…